Alto Neuroscience Inc. (ANRO)
NYSE: ANRO
· Real-Time Price · USD
3.15
0.03 (0.96%)
At close: Aug 15, 2025, 3:59 PM
3.14
-0.32%
After-hours: Aug 15, 2025, 05:05 PM EDT
Alto Neuroscience Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Revenue | n/a | n/a | 394K | n/a | n/a | n/a | 372K | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 171K | n/a | 200K | 100K | 97K | 92K | 95K | 100K | 86K | 97K |
Gross Profit | n/a | -171K | 197K | -200K | -100K | -97K | 280K | -467K | -100K | -86K | -97K |
Operating Income | -18.68M | -15.68M | -17M | -18.89M | -18.34M | -14.39M | -11.77M | -9.72M | -9.13M | -7.2M | -8.06M |
Interest Income | 1.68M | 1.83M | 2.13M | 2.5M | 2.66M | 1.56M | 738K | 714K | 667K | 230K | 112K |
Pretax Income | -17.71M | -15.17M | -15.2M | -16.78M | -16.03M | -13.42M | -11.22M | -9.14M | -8.66M | -7.28M | -7.65M |
Net Income | -17.71M | -15.17M | -15.2M | -16.78M | -16.03M | -13.42M | -11.22M | -9.14M | -8.66M | -7.28M | -7.65M |
Selling & General & Admin | 5.56M | 5.7M | 6.2M | 5.83M | 5.16M | 4.34M | 2.03M | 1.75M | 1.95M | 1.51M | 1.64M |
Research & Development | 13.12M | 9.97M | 10.8M | 13.06M | 13.18M | 9.95M | 9.64M | 7.97M | 7.07M | 5.61M | 6.32M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 92K | n/a | n/a | n/a | n/a |
Operating Expenses | 18.68M | 15.68M | 17M | 18.89M | 18.34M | 14.29M | 11.77M | 9.72M | 9.03M | 7.12M | 7.96M |
Interest Expense | -646K | 598K | 333K | 349K | 347K | 346K | 356K | 363K | 327K | 324K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -97K | -92K | n/a | -100K | -86K | -97K |
Cost & Expenses | n/a | 15.68M | 17M | 18.89M | 18.34M | 14.39M | 11.77M | 9.72M | 9.13M | 7.2M | 8.06M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 27.07M | 27.05M | 26.99M | 26.96M | 26.95M | 26.88M | 26.88M | 26.88M | 26.88M | 26.88M | 25.57M |
Shares Outstanding (Diluted) | 27.07M | 27.05M | 26.99M | 26.96M | 26.95M | 26.88M | 26.88M | 26.88M | 26.88M | 26.88M | 25.57M |
EPS (Basic) | -0.65 | -0.56 | -0.56 | -0.62 | -0.59 | -0.5 | -0.42 | -0.34 | -0.32 | -0.27 | -0.3 |
EPS (Diluted) | -0.65 | -0.56 | -0.56 | -0.62 | -0.59 | -0.5 | -0.42 | -0.34 | -0.32 | -0.27 | -0.3 |
EBITDA | -18.68M | -15.68M | -14.7M | -16.31M | -15.58M | -12.97M | -10.77M | -8.7M | -8.24M | -6.87M | -7.55M |
EBIT | n/a | -14.57M | -14.87M | -16.43M | -15.68M | -13.07M | -10.86M | -8.78M | -8.34M | -6.96M | -7.65M |
Depreciation & Amortization | n/a | 171K | 170K | 122K | 113K | 97K | 92K | 83K | 100K | 86K | 97K |